The advertisement promotes Entyvio, a medication for adults with moderate to severe ulcerative colitis, comparing its effectiveness to Humira and providing important safety information.
Creative Information
| CID: | 0efe2220-905f-4379-8ee5-3db1e67670bc |
| CRID: | 25_cq6by5co |
| Domain: | takeda.com |
| Seat: | TTD |
| Size: | 160x600 |
| Bid: | $0.83 |
| Timestamp: | 11/14/2025, 3:03:20 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/25/2025, 8:25:18 PM | 7.52s | |
| adomain_analysis | success | 11/25/2025, 8:43:52 PM | 4.52s | |
| adomain_capture | success | 11/25/2025, 8:43:48 PM | 0.22s | |
| ad_render | success | 11/25/2025, 8:25:10 PM | 25.56s | |
| brand_mapping | success | 11/25/2025, 8:23:54 PM | 0.16s | |
Analysis Results
Ad Format: banner
Brands: Takeda
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 160x600 | ||||||||||||||||||||||
| Data Transferred: | 1734.59 KB | ||||||||||||||||||||||
| Render Time: | 9.06 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1760.16 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives

